Chorioretinitis in a 7-Year-Old African Girl, Probably Related to JSSc Resolving to Methotrexate Therapy

Abstract

Juvenile systemic sclerosis (JSSc) is a rare but severe multi-system connective tissue disease of unknown etiology. It is one of the most difficult to treat rheumatic diseases in childhood and characterized by thickening and fibrosis of the skin and associated with fibrosis of internal organs. Eye involvement has rarely been reported. In a 7-year-old African girl, who presented with chorioretinitis and subsequently developed JSSc we discuss the possible association of chorioretinitis with JSSc and the putative implications of scleroderma vascular disease in the development of this complication and review the existing literature.

Zusammenfassung

Die Systemische Sklerodermie (SSc) ist eine chronische Systemerkrankung ungeklärter Ätiologie. Bei einer 7-jährigen afrikanischen Patientin mit Chorioretinitis und Visusverlust sowie sklerodermiformen Veränderungen wurde die Diagnose SSc diskutiert und die Therapie mit MTX eingeleitet.

Key words

Chorioretinitis - Scleroderma - eye involvement - systemic sclerosis - JSSc - SSc

Schlüsselwörter

Chorioretinitis - Sklerodermie - Augenbeteiligung - Systemische Sklerose - JSSc - SSc

Literatur

• 1 Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis.  N Engl J Med. 1998;  338 1186-1191
• 2 Farkas TG, Sylvester V, Archer D. The choroidopathy of progressive systemic sclerosis (scleroderma).  Am J Ophthalmol. 1972;  74 875-886
• 3 Grennan DM, Forrester J. Involvement of the eye in SLE and scleroderma. A study using fluorescein angiography in addition to clinical ophthalmic assessment.  Ann Rheum Dis. 1977;  36 152-156
• 4 Hesse RJ, Slagle 2nd DF. Scleroderma choroidopathy: report of an unusual case.  Ann Ophthalmol. 1982;  14 524-525
• 5 Martini G, Vittadello F, Kasapçopur O. et al . Factors affecting survival in juvenile systemic sclerosis. Juvenile Scleroderma Working Group of Paediatric Rheumatology European Society (PRES).  Rheumatology (Oxford). 2009;  48 119-122
• 6 McLean H, Guthrie W. Retinopathy in scleroderma.  J Am Oph Soc. 1969;  89 209-212
• 7 Milenkovic S, Petrovic L, Risimic D. et al . Choroidal sclerosis in localized scleroderma (morphea en plaque).  Ophthalmic Res. 2008;  40 101-104
• 8 Nelson JL. Microchimerism and the causation of scleroderma.  Scand J Rheumatol Suppl. 1998;  107 10-13
• 9 Nielsen NV. The normal fundus fluorescein angiogram and the normal fundus photograph.  Acta Ophthal Suppl. 1986;  180 1-30
• 10 Ohtsuka T, Miyamoto Y, Yamakage A. et al . Quantitative analysis of microchimerism in systemic sclerosis skin tissue.  Arch Dermatol Res. 2001;  293 387-391
• 11 Serup L, Serup J, Hagdrup H. Fundus fluorescein angiography in generalized scleroderma.  Ophthalmic Res. 1987;  19 303-308
• 12 Tailor R, Gupta A, Herrick A. et al . Ocular manifestations of scleroderma.  Surv Ophthalmol. 2009;  54 292-304
• 13 Zulian F, Martini G. Childhood systemic sclerosis.  Curr Opin Rheumatol. 2007;  19 592-597

Korrespondenzadresse